These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25079513)

  • 1. Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.
    van Mens SP; van Deursen AMM; de Greeff SC; de Melker HE; Schouls LM; van der Ende A; Bonten MJM; Sanders EAM; Vlaminckx BJM
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):115-122. PubMed ID: 25079513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia.
    Kim B; Kim J; Jo YH; Lee JH; Hwang JE; Park MJ; Lee S
    PLoS One; 2018; 13(7):e0200620. PubMed ID: 30028834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.
    Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M
    Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors associated with negative urinary antigen tests implemented for the diagnosis of community-acquired pneumococcal pneumonia in adult patients.
    Watanabe H; Uruma T; Tazaki G; Kikuchi R; Tsuji T; Itoh M
    Med Princ Pract; 2015; 24(2):189-94. PubMed ID: 25613456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.
    Ceccato A; Torres A; Cilloniz C; Amaro R; Gabarrus A; Polverino E; Prina E; Garcia-Vidal C; Muñoz-Conejero E; Mendez C; Cifuentes I; Puig de la Bella Casa J; Menendez R; Niederman MS
    Chest; 2017 Jun; 151(6):1311-1319. PubMed ID: 28093269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes.
    Choi MJ; Song JY; Cheong HJ; Jeon JH; Kang SH; Jung EJ; Noh JY; Kim WJ
    J Infect Chemother; 2015 Sep; 21(9):672-9. PubMed ID: 26212866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome.
    Blanc V; Mothes A; Smetz A; Timontin I; Guardia MD; Billiemaz A; Dellamonica J; Vassallo M; Néri D; Chadapaud S; Toyer AL; Del Guidice P; Fribourg A; Léotard S; Nicolle I; Roger PM
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2455-61. PubMed ID: 26476549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients.
    Zalacain R; Capelastegui A; Ruiz LA; Bilbao A; Gomez A; Uranga A; España PP
    Respirology; 2014 Aug; 19(6):936-43. PubMed ID: 24976113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal urinary antigen testing for antimicrobial guidance in community-acquired pneumonia-A register-based cohort study.
    Athlin S; Magnuson A; Spindler C; Hedlund J; Strålin K; Nauclér P
    J Infect; 2022 Aug; 85(2):167-173. PubMed ID: 35618153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study.
    Bellut H; Porcher R; Varon E; Asfar P; Le Tulzo Y; Megarbane B; Mathonnet A; Dugard A; Veinstein A; Ouchenir K; Siami S; Reignier J; Galbois A; Cousson J; Preau S; Baldesi O; Rigaud JP; Souweine B; Misset B; Jacobs F; Dewavrin F; Mira JP; Bedos JP
    Ann Intensive Care; 2021 Oct; 11(1):148. PubMed ID: 34689255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study.
    Kobayashi E; Yamaguchi K; Nagaoka R; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Yokozaki M; Ohge H; Hamada H; Hattori N
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):871-877. PubMed ID: 33150516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.
    Bellew S; Grijalva CG; Williams DJ; Anderson EJ; Wunderink RG; Zhu Y; Waterer GW; Bramley AM; Jain S; Edwards KM; Self WH
    Clin Infect Dis; 2019 May; 68(12):2026-2033. PubMed ID: 30265290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Yamazaki A; Washio Y
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115457. PubMed ID: 34271234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.
    Wagenvoort GH; Sanders EA; de Melker HE; van der Ende A; Vlaminckx BJ; Knol MJ
    Vaccine; 2017 Mar; 35(14):1749-1757. PubMed ID: 28262334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia.
    Yin JK; Jayasinghe SH; Charles PG; King C; Chiu CK; Menzies RI; McIntyre PB
    Med J Aust; 2017 Nov; 207(9):396-400. PubMed ID: 29092707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy.
    Mothes A; Léotard S; Nicolle I; Smets A; Chirio D; Rotomondo C; Tiger F; Del Giudice P; Perrin C; Néri D; Foucault C; Della Guardia M; Hyvernat H; Roger PM;
    Med Mal Infect; 2016 Oct; 46(7):365-371. PubMed ID: 27377444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.